TranScience is a Business Consulting & Services company helping Healthcare clients with Critical Commercial Talent Acquisition, Organisation Performance & Change Management and Market Access. TranScience is led by deep capabilities in integrating unique market requirements of different APAC markets, for various healthcare companies. The Solutions & Services are tailored for large as well as early and small organisations.
We operate out of two major healthcare markets today – Australia and India. Our team’s cumulative experience, contextual rigour, understanding of the client’s business challenges and close relationships, position us strongly in this niche space, and we help build high performing business teams for our clients.
At TranScience, we are exclusively focused on making the Healthcare companies successful, in emerging as well as developed markets of APAC – Australia, South East Asia and India, with targeted Commercial and Healthtech Talent Hiring, Business Performance & Change Solutions. It is our deep product, therapy and org capability understanding, along with the ability to identify and engage with best-in-class healthcare business talent in the above markets, that sets us apart.
Industry Focus – Medical Technology, Medical Diagnostics, Biotechnology, CROs, Hospitals, Pharmaceuticals
APAC Markets served – Australia, India, Southeast Asia (Thailand, Vietnam, Indonesia, Malaysia)
Binayak Bagchi, is the Founding Director of TranScience, and is a Business Transformation & Change HR expert with 25 years in designing and leading People Strategies of organizations, during Strategic Shifts, Early Market Entries, M&A and Divestiture, across markets of APAC - Australia, Southeast Asia, Singapore, India, Japan, China, S Korea, with sustainable results over years.
Binayak has various Leadership experiences at Global and Regional level and has worked across multiple international locations like US, Singapore, Australia, India, and a few other, for companies like Medtronic, Avanos Medical, UnitedHealth Group, and AON Hewitt. He is an experienced Executive Coach.
Binayak has a Master’s Degree in Business Change Consulting from INSEAD and is a Doctoral researcher in Management.
He is based out of Sydney, Australia.
Mentor & Advisor - Strategy
Jamie brings over four decades of experience in the healthcare industry and was the longest serving (17+ years) Managing Director of Medtronic ANZ, in which period it touched 1 billion AUD annual turnover. Jamie has been advising the formation of Transcience and its business offerings, and acts as a Mentor to the team.
Advisor - Market Access
Aijaz is a Senior Business Executive and an exceptional Marketing Leader with ability to accelerate Innovation & Business Growth. He has lead several Global and Regional Product transformation initiatives at various companies including Medtronic and Avanos Medical and has deep and broad expertise in ANZ, APAC and Global markets.
Advisor - Communications
Gilda is a young and dynamic digital strategy, marketing creative and communications expert, with experiences in Startups, Not for Profit and Early Tech organizations. Gilda has been closely involved in shaping the thinking, design and content of TranScience in the above areas.
Advisor - Technology & Data Science
Vivek has several decades of IT/ITeS leadership experience at companies like Xerox, AON Hewitt, Ericsson and NIIT. Vivek has proven track record in driving sustainable business growth by leveraging technology & business services to serve Fortune 500 as well as Startups. Vivek advises TranScience on the HR Tech solutions for clients.
Managing Partner, India Talent Operations
Swarup is an executive search expert with three decades of experience in Healthcare and Technology hiring, and has helped several large and small companies hire critical business talent in Indian Subcontinent. You can reach him at swarup@transcienceworks.com
Early medtech companies in Asia today faces several human capital challenges for growth-
Skills Gap : There are big gaps between skills and
Author - Binayak Bagchi
Like many other countries, Australia faces several integrated healthcare challenges. I am going to talk of a few here:
Fragmented Systems :
Author - Binayak Bagchi
Market Access is defined by the bringing of products or solutions to the right patient at the right price points in a timely manner
Author - Aijaz Shaikh
Early MedTech Company Challenges of Asia
Early medtech companies in Asia today faces several human capital challenges for growth-
Skills Gap : There are big gaps between skills and qualifications of available workforce, particularly specialized skills in this sector, hindering innovation & growth.
Education & Training : Adequate training programs and educational institutions specializing in medtech are lacking in most Asian countries, making it difficult to produce skilled workforce for the sector.
Regulatory Compliance : The medtech sector requires deep understanding of regulatory compliance. Shortage in this field is slowing down growth and product development in Asia.
Language & Culture : In many parts of Asia, language and cultural barriers can be a challenge when trying to attract talent from diverse backgrounds, including expatriates.
Intellectual Property Concerns : Protecting intellectual property is crucial in the medtech industry. Lack of strong IP protection laws often deter investment in Asia
Market Competition : Intense competition for skilled professionals in the medtech sector can drive up labor costs, making it challenging for smaller companies to attract and retain talent.
Having a smart Human Capital Partner for capitalising your Asia Growth Aspirations is key for success!
Author - Binayak Bagchi
Integrated Healthcare or Fragmented!
Like many other countries, Australia faces several integrated healthcare challenges. I am going to talk of a few here:
Fragmented Systems : The Australian healthcare system consists of both public and private sectors, often leading to fragmented care delivery and challenges of coordination.
Information Sharing : Integrating patient information across healthcare providers while maintaining patient privacy/ data security is complex.
Communication : Ensuring effective communication and collaboration among various healthcare professionals, organizations, can be difficult.
Funding : Funding across different parts of the healthcare system to support integrated care models can be a challenge.
Cultural Differences : Different healthcare organizations have varying cultures, practices, and priorities, making it challenging to align efforts.
Legal & Regulatory : Navigating these frameworks, especially when sharing patient data across organizations, can be a barrier to integration.
Technology : Implementing and maintaining compatible technologies for sharing medical records can be technically complex and resource-intensive.
Patient Engagement : Encouraging patients to actively participate in their integrated care plans is a challenge.
Resistance to Change : NHealthcare professionals are resistant to new models of care requiring changes in their roles, responsibilities, and workflows.
Measuring Outcomes : Defining and measuring the success of integrated care models around patient outcomes and cost is challenging.
Addressing the above requires coordinated effort from policymakers, healthcare providers, organizations, and patients, to create a more integrated, patient-centered healthcare system.
Author - Binayak Bagchi
Accelerating market access for medtech industry in APAC
Market Access is defined by the bringing of products or solutions to the right patient at the right price points in a timely manner through the efficient enablement of registrations, reimbursement, listing, training and supply.
As Asia Pacific continues to undergo unprecedented demographic changes, the need for a holistic approach to transform healthcare delivery has never been greater. Addressing the growing demand for healthcare in a fragmented region with disparate regulatory regimes, complex reimbursement systems, and conflicting policy priorities, requires a different kind of innovative thinking from all stakeholders across the MedTech ecosystem.
Market access has previously been more focused on pricing and reimbursement. However, driven by the ever-changing healthcare macro-environment, the move from price-based to value-based approaches and companies developing more unconventional business models, other elements such as regulatory, supply chain & channels, training & education (beyond physicians), stakeholders & KOL management and financing are becoming increasingly relevant.
Healthcare policies within Asia are rapidly developing. It is thus impossible to apply a standard strategy across the entire region. Local knowledge is critical to identify the structure, stakeholders and processes. Medtech companies looking to enter or scale in Asia will have to consider long-term implications of how the market landscape is evolving and build up their capabilities to deliver measured and meaningful propositions backed by impactful data in order to build up sustainable businesses in the region.
Regulatory Compliance : The medtech sector requires deep understanding of regulatory compliance. Shortage in this field is slowing down growth and product development in Asia.
Language & Culture : In many parts of Asia, language and cultural barriers can be a challenge when trying to attract talent from diverse backgrounds, including expatriates.
Intellectual Property Concerns : Protecting intellectual property is crucial in the medtech industry. Lack of strong IP protection laws often deter investment in Asia
Market Competition : Intense competition for skilled professionals in the medtech sector can drive up labor costs, making it challenging for smaller companies to attract and retain talent.
Having a smart Human Capital Partner for capitalising your Asia Growth Aspirations is key for success!
Author - Aijaz Shaikh
Early medtech companies in Asia today faces several human capital challenges for growth-
Skills Gap : There are big gaps between skills and qualifications of available workforce, particularly specialized skills in this sector, hindering innovation & growth.
Education & Training : Adequate training programs and educational institutions specializing in medtech are lacking in most Asian countries, making it difficult to produce skilled workforce for the sector.
Regulatory Compliance : The medtech sector requires deep understanding of regulatory compliance. Shortage in this field is slowing down growth and product development in Asia.
Language & Culture : In many parts of Asia, language and cultural barriers can be a challenge when trying to attract talent from diverse backgrounds, including expatriates.
Intellectual Property Concerns : Protecting intellectual property is crucial in the medtech industry. Lack of strong IP protection laws often deter investment in Asia
Market Competition : Intense competition for skilled professionals in the medtech sector can drive up labor costs, making it challenging for smaller companies to attract and retain talent.
Having a smart Human Capital Partner for capitalising your Asia Growth Aspirations is key for success!
Author - Binayak Bagchi
Like many other countries, Australia faces several integrated healthcare challenges. I am going to talk of a few here:
Fragmented Systems : The Australian healthcare system consists of both public and private sectors, often leading to fragmented care delivery and challenges of coordination.
Information Sharing : Integrating patient information across healthcare providers while maintaining patient privacy/ data security is complex.
Communication : Ensuring effective communication and collaboration among various healthcare professionals, organizations, can be difficult.
Funding : Funding across different parts of the healthcare system to support integrated care models can be a challenge.
Cultural Differences : Different healthcare organizations have varying cultures, practices, and priorities, making it challenging to align efforts.
Legal & Regulatory : Navigating these frameworks, especially when sharing patient data across organizations, can be a barrier to integration.
Technology : Implementing and maintaining compatible technologies for sharing medical records can be technically complex and resource-intensive.
Patient Engagement : Encouraging patients to actively participate in their integrated care plans is a challenge.
Resistance to Change : NHealthcare professionals are resistant to new models of care requiring changes in their roles, responsibilities, and workflows.
Measuring Outcomes : Defining and measuring the success of integrated care models around patient outcomes and cost is challenging.
Addressing the above requires coordinated effort from policymakers, healthcare providers, organizations, and patients, to create a more integrated, patient-centered healthcare system.
Author - Binayak Bagchi
“Market Access is defined by the bringing of products or solutions to the right patient at the right price points in a timely manner through the efficient enablement of registrations, reimbursement, listing, training and supply”.
As Asia Pacific continues to undergo unprecedented demographic changes, the need for a holistic approach to transform healthcare delivery has never been greater. Addressing the growing demand for healthcare in a fragmented region with disparate regulatory regimes, complex reimbursement systems, and conflicting policy priorities, requires a different kind of innovative thinking from all stakeholders across the MedTech ecosystem.
Market access has previously been more focused on pricing and reimbursement. However, driven by the ever-changing healthcare macro-environment, the move from price-based to value-based approaches and companies developing more unconventional business models, other elements such as regulatory, supply chain & channels, training & education (beyond physicians), stakeholders & KOL management and financing are becoming increasingly relevant.
Healthcare policies within Asia are rapidly developing. It is thus impossible to apply a standard strategy across the entire region. Local knowledge is critical to identify the structure, stakeholders and processes. Medtech companies looking to enter or scale in Asia will have to consider long-term implications of how the market landscape is evolving and build up their capabilities to deliver measured and meaningful propositions backed by impactful data in order to build up sustainable businesses in the region.
Regulatory Compliance : The medtech sector requires deep understanding of regulatory compliance. Shortage in this field is slowing down growth and product development in Asia.
Language & Culture : In many parts of Asia, language and cultural barriers can be a challenge when trying to attract talent from diverse backgrounds, including expatriates.
Intellectual Property Concerns : Protecting intellectual property is crucial in the medtech industry. Lack of strong IP protection laws often deter investment in Asia
Market Competition : Intense competition for skilled professionals in the medtech sector can drive up labor costs, making it challenging for smaller companies to attract and retain talent.
Having a smart Human Capital Partner for capitalising your Asia Growth Aspirations is key for success!
Author - Aijaz Shaikh
